The importance of standardisation of laboratory evaluations in HIV vaccine trialsGOTCH, Frances; HOLMES, Harvey; IMAMI, Nesrina et al.Microbes and infection. 2005, Vol 7, Num 14, pp 1424-1432, issn 1286-4579, 9 p.Article

Novel approach to recognition of predicted HIV-1 Gag B*3501-restricted CD8 T-cell epitopes by HLA-B*3501⁺ patients : Confirmation by quantitative ELISpot analyses and characterisation using multimersWESTROP, Samantha I; GRAGEDA, Nathali; IMAMI, Nesrina et al.Journal of immunological methods. 2009, Vol 341, Num 1-2, pp 76-85, issn 0022-1759, 10 p.Article

Initiation of antiretroviral therapy during recent HIV-1 infection results in lower residual viral reservoirsPIRES, Antonio; HARDY, Gareth; GAZZARD, Brian et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 3, pp 783-790, issn 1525-4135, 8 p.Article

T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsivenessDOWNEY, Jocelyn S; ATTAF, Meriem; MOYLE, Graeme et al.AIDS (London). 2011, Vol 25, Num 16, pp 1981-1986, issn 0269-9370, 6 p.Article

Distinct patterns of peripheral HIV-1-specific interferon-γ responses in exposed HIV-1-seronegative individualsKEBBA, Anthony; KALEEBU, Pontiano; ROWLAND, Samantha et al.The Journal of infectious diseases. 2004, Vol 189, Num 9, pp 1705-1713, issn 0022-1899, 9 p.Article

Specificity of anti-human leukocyte antigen antibody responses after immunization with remune, an inactivated HIV-1 vaccinePAGE, Mark; OJUGO, Agatha; IMAMI, Nesrina et al.AIDS (London). 2007, Vol 21, Num 3, pp 375-377, issn 0269-9370, 3 p.Article

Enhanced T-cell maturation, differentiation and function in HIV-1-infected individuals after growth hormone and highly active antiretroviral therapyPIRES, Antonio; PIDO-LOPEZ, Jeffrey; MOYLE, Graeme et al.Antiviral therapy (London). 2004, Vol 9, Num 1, pp 67-75, issn 1359-6535, 9 p.Article

Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphomaPOWLES, Tom; IMAMI, Nesrina; NELSON, Mark et al.AIDS (London). 2002, Vol 16, Num 4, pp 531-536, issn 0269-9370Article

HIV type 1 antigen-responsive CD4⁺ T-lymphocytes in exposed yet HIV type 1 seronegative ugandansKEBBA, Anthony; KALEEBU, Pontiano; SERWANGA, Jennifer et al.AIDS research and human retroviruses. 2004, Vol 20, Num 1, pp 67-75, issn 0889-2229, 9 p.Article

Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patientsROSIGNOLI, Guglielmo; CRANAGE, Alison; BURTON, Catherine et al.AIDS (London). 2007, Vol 21, Num 10, pp 1379-1381, issn 0269-9370, 3 p.Article

Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune)PIDO-LOPEZ, Jeffrey; BURTON, Catherine; HARDY, Gareth et al.AIDS research and human retroviruses. 2003, Vol 19, Num 2, pp 103-109, issn 0889-2229, 7 p.Article

A point mutation in CD45 may be associated with an increased risk of HIV-1 infectionTCHILIAN, Elma Z; WALLACE, Diana L; DAWES, Ritu et al.AIDS (London). 2001, Vol 15, Num 14, pp 1892-1894, issn 0269-9370Article

HIV type 1-specific inter- and intrasubtype cellular immune responses in HIV type 1-infected ugandansRUTEBEMBERWA, Alleluiah; AUMA, Betty; GOTCH, Frances et al.AIDS research and human retroviruses. 2004, Vol 20, Num 7, pp 763-771, issn 0889-2229, 9 p.Article

A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responsesMALNATI, Mauro S; HELTAI, Silvia; NOZZA, Silvia et al.Journal of immunological methods. 2012, Vol 375, Num 1-2, pp 46-56, issn 0022-1759, 11 p.Article

Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infectionMORLESE, John F; ORKIN, Chloë M; ABBAS, Riaz et al.AIDS (London). 2003, Vol 17, Num 9, pp 1411-1413, issn 0269-9370, 3 p.Article